Metraipolis › archive › dc_a1bd0da9de67
Target-Specific Dermatological Adverse Event Reporting With T-Cell-Engaging Bispecific Antibodies: A Pharmacovigilance Analysis of FAERS and Canada Vigilance,… — Europe PMC PMID:42670250
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42670250
- DOI
- 10.1002/cam4.72241
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-16T12:31:20.608Z
- SHA-256 of the archived text
066cdf581b10ecaad0c82b4d4b8926a2c1e81166c1b889e0c0f84abc63348499- Stable URL of this page
https://metraipolis.com/documento/dc_a1bd0da9de67
How to cite
Target-Specific Dermatological Adverse Event Reporting With T-Cell-Engaging Bispecific Antibodies: A Pharmacovigilance Analysis of FAERS and Canada Vigilance,… — Europe PMC PMID:42670250 — Europe PMC (en), https://europepmc.org/article/MED/42670250 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a1bd0da9de67 (Metraipolis archive dc_a1bd0da9de67, sha256 066cdf581b10ecaad0c82b4d4b8926a2c1e81166c1b889e0c0f84abc63348499)
BibTeX
@misc{dca1bd0da9de67,
title = {Target-Specific Dermatological Adverse Event Reporting With T-Cell-Engaging Bispecific Antibodies: A Pharmacovigilance Analysis of FAERS and Canada Vigilance,… — Europe PMC PMID:42670250},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42670250},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a1bd0da9de67; sha256 066cdf581b10ecaad0c82b4d4b8926a2c1e81166c1b889e0c0f84abc63348499},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42670250. Agents can read the archived copy with the MCP tool read_document.